Hydrochloride salts of a glycopeptide phosphonate derivative

Details for Australian Patent Application No. 2004285924 (hide)

Owner Theravance, Inc.

Inventors Lee, Junning; Liu, Jyanwei

Agent Davies Collison Cave

Pub. Number AU-B-2004285924

PCT Pub. Number WO2005/042568

Priority 60/513,359 22.10.03 US

Filing date 21 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 24 February 2011

International Classifications

C07K 9/00 (2006.01) Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/042568 Priority application(s): WO2005/042568

24 February 2011 Application Accepted

  Published as AU-B-2004285924

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285925-Improved process for preparing benzhydrylthioacetamide

2004285923-Nucleoside compounds for treating viral infections